Literature DB >> 11277611

Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen.

M R Turner1, N Gainsborough.   

Abstract

We present the case of a 36-year-old man who presented with a clinically neuroleptic malignant-like syndrome involving disorientation, signs of autonomic dysfunction, rigidity and raised total creatine kinase level, but in the absence of any neuroleptic medication. He had, however, abruptly stopped taking his long-term baclofen in the days prior to presentation. He improved markedly after the reintroduction of baclofen, and we postulate that his clinical syndrome resulted from the sudden withdrawal of this drug. We concur with the concept that neuroleptic malignant syndrome represents a spectrum of disorders, and add it to the list of possible sequelae after abrupt withdrawal of baclofen.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277611     DOI: 10.1177/026988110101500111

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  8 in total

1.  Intrathecal baclofen withdrawal syndrome following posterior spinal fusion for neuromuscular scoliosis: a case report.

Authors:  Pedro Fernandes; Lori Dolan; Stuart L Weinstein
Journal:  Iowa Orthop J       Date:  2008

Review 2.  Autonomic dysfunction in the neurological intensive care unit.

Authors:  Max J Hilz; Mao Liu; Sankanika Roy; Ruihao Wang
Journal:  Clin Auton Res       Date:  2018-07-18       Impact factor: 4.435

Review 3.  Acute intrathecal baclofen withdrawal: a brief review of treatment options.

Authors:  James C Ross; Aaron M Cook; Gary L Stewart; Brenda G Fahy
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

4.  Estimating the National Population of Hospitalized Chronic Baclofen Users: A Cross-Sectional Analysis of a Commercial Claims Database.

Authors:  Natalie Schmitz; Margaret Artz; Karen Walsh; Sandeep Gaudana; James Cloyd; John Schrogie; Robert Kriel
Journal:  Drugs Real World Outcomes       Date:  2022-03-31

Review 5.  A benefit-risk assessment of baclofen in severe spinal spasticity.

Authors:  Alessandro Dario; Giustino Tomei
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  Treatment of paroxysmal sympathetic hyperactivity.

Authors:  Alejandro A Rabinstein; Eduardo E Benarroch
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

7.  Neuroleptic malignant syndrome: a review for neurohospitalists.

Authors:  Brian D Berman
Journal:  Neurohospitalist       Date:  2011-01

8.  Baclofen and gamma-hydroxybutyrate withdrawal.

Authors:  Jennifer L LeTourneau; Daniel S Hagg; Stephen M Smith
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.